HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 1,874.478 million compared to CNY 1,965.282 million a year ago. Operating income was CNY 64.730 million compared to CNY 98.038 million a year ago. Net income was CNY 48.296 million compared to CNY 73.518 million a year ago. Basic earnings per share from continuing operations was CNY 0.0833 compared to CNY 0.1268 a year ago.